✦ LIBER ✦

Open-label extension study on the long-term efficacy, safety, and impact on quality of life of OROS® hydromorphone extended release in patients with chronic low back pain

✍ Scribed by M. Wallace; J. Thipphawong

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Open-Label Study on the Long-Term Effica

✍ Mark Wallace; John Thipphawong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Poster 269: Open-label Extension Study o

✍ Mark S. Wallace; John Thipphawong 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 58 KB

(806): Long-term safety and efficacy of

✍ M. Wallace; R. Skowronski; S. Khanna; N. Abrouk; J. Thipphawong 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Opioids in non-cancer pain: Open-label,

✍ M. Hale; M. Tark 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

(809): Clinical and quality of life bene

✍ M. Wallace; R. Skowronski; S. Khanna; N. Abrouk; J. Thipphawong 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 47 KB

342 DOSE STABILITY OF TAPENTADOL EXTENDE

✍ S. Grond; B. Kuperwasser; B. McCann; M. Etropolski; R. Lange; B. Lange; A. Okamo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 61 KB